结构化教育管理在癌症标准化治疗中的应用 疼痛 癌症 疼痛
Hai-Hui Zhou1,2, Guo-Qing Xiao3, Qi Zhu3
1Department of Pharmacy, Geriatric Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. zhhhnj@126.com.
概括
结构化教育通过增强疼痛控制和减少不良事件,显著改善了癌症疼痛管理. 这种方法赋予患者权力,导致更好的结果和更少的药物使用.
科学领域:
- 在瘤学瘤学.
- 疼痛管理 疼痛管理
- 临床药房 临床药房
背景情况:
- 中国的癌症疼痛管理受到患者知识差距和缺乏信心的阻碍,导致不有效的症状控制.
- 标准化治疗方案存在,但可能无法完全满足患者特定的需求和理解.
- 建议采用结构化的教育方法来增强现有的癌症疼痛治疗策略.
研究的目的:
- 评估结构化教育管理在标准化癌症疼痛治疗中的有效性.
- 将接受标准护理的患者和接受额外结构化教育的患者之间的疼痛控制,治疗疗效和不良事件进行比较.
- 评估临床药剂师主导教育对癌症疼痛管理患者结果的影响.
主要方法:
- 采用了追溯病例控制研究设计,将干预组与对照组进行比较.
- 对照组接受了基于三步止痛方法的标准止痛治疗.
- 干预组除了接受标准治疗外,还接受了结构化的癌症疼痛教育,在入学时和干预后两周进行评估.
主要成果:
- 两组都在疼痛控制障碍得分和NRS得分方面表现出改善,干预组的得分明显较低.
- 干预组实现了更高的总有效止痛率,并且需要更低的等效吗啡剂量.
- 干预组中便秘,恶心,吐和疲劳等不良事件显著减少,皮疹发生率没有显著差异.
结论:
- 临床药剂师领导的结构化教育是改善癌症疼痛管理治疗效果的宝贵工具.
- 这种教育干预显著提高了疼痛控制,并减少了常见不良反应的发生率.
- 结构化教育赋予患者权力,为更有效,更安全的癌症疼痛管理策略做出贡献.
相关概念视频
Analgesia and Pain Management
420
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
420
Cancer Survival Analysis
318
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
318
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Chronic Pancreatitis II: Collaborative Care
56
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
56


